US Patent Issued to Memorial Sloan Kettering Cancer Center on Jan. 27 for "Methods of selecting T cell line and donor thereof for adoptive cellular therapy" (New York, Pennsylvania, Connecticut Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,533,407, issued on Jan. 27, was assigned to Memorial Sloan Kettering Cancer Center (New York).

"Methods of selecting T cell line and donor thereof for adoptive cellular therapy" was invented by Richard J. O'Reilly (Roxbury, Conn.), Ekaterina Doubrovina (Bronx, N.Y.), Guenther Koehne (New York), Aisha N. Hasan (Blue Bell, Pa.) and Susan E. Prockop (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of selecting an allogeneic T cell line for therapeutic administration to a patient having or suspected of having a pathogen or cancer. Also disclosed are methods of selecting a donor from whom to derive an allogeneic T cell li...